Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03553849 · ClinicalTrials.gov registry record · NA
Utilization of Very Low Calorie Diet in Obese General Surgery Patients
A NA study of Morbid Obesity, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT03553849: Completed NA study of Morbid Obesity, sponsored by Christiana Care Health Services.
NCT03553849 is a NA study of Morbid Obesity that has completed, run by Christiana Care Health Services. The registered enrollment target is 58 participants, below the 120-participant average among 24 other Morbid Obesity trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03553849, a NA study of Morbid Obesity, has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are studying the use of a two-week very low calorie diet (VLCD) in obese general surgery patients in a randomized single-blinded trial. The investigators hypothesize that the VLCD will positively impact the perceived surgical difficulty, operative time, hospital length of stay and 30-day complications. Additionally, the investigators anticipate reduced perioperative blood glucose levels and a reduced need for perioperative insulin administration.
Primary Outcome
Pulmonary, cardiac and surgical complications using data collected from inpatient and outpatient charting
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Very low calorie diet
Study Locations (1)
Delaware
- Christiana Care Health System - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2018-09-24 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
What the finished NCT03553849 record still lists
NCT03553849 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 120-participant average among 24 other Morbid Obesity trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Morbid Obesity appearing as the primary indexed condition, and to 1 intervention - of which Very low calorie diet is the first listed.
NCT03553849 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT03553849 about?
NCT03553849 is a clinical study titled "Utilization of Very Low Calorie Diet in Obese General Surgery Patients". The investigators are studying the use of a two-week very low calorie diet (VLCD) in obese general surgery patients in a randomized single-blinded trial. The investigators hypothesize that the VLCD will positively impact the perceived surgical difficulty, operative time, hospital length of stay and ...
What is the current status of trial NCT03553849?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2018-09-24. Estimated completion is 2020-12-31.
What conditions does trial NCT03553849 study?
This clinical trial studies the following conditions: Morbid Obesity.
What interventions are being tested in trial NCT03553849?
The interventions under investigation include: Very low calorie diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03553849?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03553849 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Morbid Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03553849's enrollment target sits among peer trials
58 17th of 24 higher than 8 of 24 other Morbid Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Morbid Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
RECRUITING · NA
-
Activity Level Monitoring Study
ACTIVE NOT RECRUITING · NA
-
Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates
COMPLETED · NA
-
Laparoscopic Adjustable Gastric Banding as a Treatment for Morbid Obesity in Adolescents
COMPLETED · NA
-
Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity
COMPLETED · NA
-
Effect of CPAP on Fetal pH at Scheduled C-section in Morbidly Obese Women
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI